Expense-hit Dr Reddy's set for first NDA filing

Dr Reddy's Laboratories has reported a 17% decline in net profits at INR5.7bn ($93m) for the second quarter ended September, weighed down by higher operating expenses. Consolidated revenues for the period rose by 7% to INR35.9bn.